Arthropod-borne viruses (Arboviruses) are viruses that can be transmitted to man by arthropod vectors. The WHO definition is as follows Viruses maintained in nature principally, or to an important extent, through biological transmission between susceptible vertebrate hosts by haematophagus arthropods or through transovarian and possibly venereal transmission in arthropods. Arboviruses belong to three families 1. Togaviruses e.g. EEE, WEE, VEE, Chikungunya & -Sindbis fever 2. Bunyaviruses e.g. Sandfly Fever, Rift Valley Fever, Crimean-Congo Haemorrhagic Fever 3. Flaviviruses e.g. Yellow Fever, dengue, Japanese Encephalitis, West Nile, KFD.
Man - arthropod -man e.g. dengue, urban yellow fever. Reservoir may be in either man or arthropod vector. In the latter transovarial transmission may take place. Animal - arthropod vector - man e.g. Japanese encephalitis, EEE, WEE, jungle yellow fever. The reservoir is an animal. The virus is maintained in nature in a transmission cycle involving the arthropod vector and animal. Man becomes infected incidentally. Both cycles may be seen with some arboviruses such as yellow fever.
Mosquitoes Japanese encephalitis, dengue, yellow fever, St. Louis encephalitis, EEE, WEE, VEE etc. Ticks Crimean-Congo haemorrhagic fever, various tick-borne encephalitides etc. Sandflies Sicilian sandfly fever, Rift valley fever.
In many cases, the actual reservoir is not known. The following animals are implicated as reservoirs Birds Japanese encephalitis, St Louis encephalitis, EEE, WEE Pigs Japanese encephalitis Monkeys Yellow Fever Rodents VEE, Russian Spring-Summer encephalitis
Fever and rash - this is usually a non-specific illness resembling a number of other viral illnesses such as influenza, rubella, and enterovirus infections. The patients may go on to develop encephalitis or haemorrhagic fever. Encephalitis - e.g. EEE, WEE, St Louis encephalitis, Japanese encephalitis. Haemorrhagic fever - e.g. yellow fever, dengue, Crimean- Congo haemorrhagic fever.
Serology - usually used to make a diagnosis of arbovirus infections. ELISA, CFT Culture - a number of cell lines may be used, including mosquito cell lines. However, it is rarely carried out since many of the pathogens are group 3 or 4 pathogens. Direct detection tests - e.g detection of antigen and nucleic acids are available but again there are safety issues. Animal Inoculation – Mouse intra cerebral inoculation.
Surveillance - of disease and vector populations Control of vector - pesticides, elimination of breeding grounds Personal protection - screening of houses, bed nets, insect repellants Vaccination - available for a number of arboviral infections e.g. Yellow fever, Japanese encephalitis, Russian tick- borne encephalitis
First discovered and originally restricted to Japan. Now large scale epidemics occur in China, India and other parts of Asia. Flavivirus, transmitted by culex mosquitoes. The virus is maintained in nature in a transmission cycle involving mosquitoes, birds and pigs. Most human infections are subclinical: the inapparent to clinical cases is 300:1 In clinical cases, a life-threatening encephalitis occurs. The disease is usually diagnosed by serology. No specific therapy is available. Since Culex has a flight range of 20km, all local control measures will fail. An effective vaccine is available.
Flavivirus, mainly found in West Africa and S America Yellow fever occurs in 2 major forms: urban and jungle (sylvatic) yellow fever. Jungle YF is the natural reservoir of the disease in a cycle involving nonhuman primates and forest mosquitoes. Man may become incidentally infected on venturing into jungle areas. The urban form is transmitted between humans by the Aedes aegypti mosquito Classically Yellow Fever presents with chills, fever, and headache. Generalized myalgias and GI complaints (N+V). Some patients may experience an asymptomatic infection or a mild undifferentiated febrile illness.
After a period of 3 to 4 days, the more severely ill patients with a classical YF course will develop bradycardia (Faget's sign), jaundice, and haemorrhagic manifestations. 50% of patients with frank YF will develop fatal disease characterized by severe haemorrhagic manifestations, oliguria and hypotension. Diagnosis is usually made by serology There is no specific antiviral treatment An effective live attenuated vaccine is available against yellow fever and is used for persons living in or traveling to endemic areas.
Dengue breakbone fever is the biggest arbovirus problem in the world today with over 2 million cases per year. Dengue is found in SE Asia, Africa and the Caribbean and S America. Flavivirus, 4 serotypes, transmitted by Aedes mosquitoes which reside in water-filled containers. Human infections arise from a human-mosquitoe-human cycle Classically, dengue presents with a high fever, lymphadenopathy, myalgia, bone and joint pains, headache, and a maculopapular rash. Severe cases may present with haemorrhagic fever and shock with a mortality of 5-10%. (Dengue haemorrhagic fever or Dengue shock syndrome.)
Dengue haemorrhagic fever (DHF)and shock syndrome (DSS) appear most often in patients previously infected by a different serotype of dengue, thus suggesting an immunopathological mechanism. Diagnosis is made by serology. No specific antiviral therapy is available. Prevention of dengue in endemic areas depends on mosquito eradication. The population should remove all containers from their premises which may serve as vessels for egg deposition. A live attenuated vaccine is being tried in Thailand with encouraging results.
- Epidemic in karnataka in Epizootic in Monkeys - fatal disease - Forest birds and small mammals are reservoirs - Tick - Haemaphysalis spinigera is vector - Monkeys are the amplifier hosts - Accidental infection in humans - Fever with massive haemorrhages in GIT, chest & nose -Vaccine available is killed vaccine -Lab diagnosis of Flavi viruses I. Mice inoculation 2. Cell culture 3. IgM ELISA
Chikungunya derived in the Kimakonde language, meaning "to become contorted" and describes the stooped appearance of sufferers with joint pain. Spread by mosquitoes. Causes fever and severe joint pain. Other symptoms include muscle pain, headache, nausea, fatigue and rash. Shares some clinical signs with dengue, and can be misdiagnosed in areas where dengue is common. No cure for the disease. Treatment focused on relieving the symptoms. The proximity of mosquito breeding sites to human habitation is a significant risk factor for chikungunya. The disease occurs in Africa, Asia and the Indian subcontinent. In recent decades mosquito vectors of chikungunya have spread to Europe and the Americas. In 2007, disease transmission was reported for the first time in Europe, in a localized outbreak in north-eastern Italy.